The Healthcare Outlook: Macro Challenges and Biotech Innovations

In this episode of Goldman Sachs Exchanges, Allison Nathan interviews Asad Haider, who leads U.S. healthcare sector coverage for Goldman Sachs research, about the underperformance of the healthcare sector relative to the S&P 500, the factors driving this trend, including macro and microeconomic issues, policy overhangs, and innovation. They also discuss the impact of policy shifts on vaccine distribution, NIH funding cuts, and potential areas of innovation like obesity treatments, oncology, and AI. Later, Amit Sinha, Head of Life Sciences Investing at Goldman Sachs Asset Management, discusses the biotech bear market, the role of private capital, and innovations in genetics, immunology, cell therapy, and AI, as well as the challenges posed by the shifting policy landscape and growth areas like cancer, incretins, and healthspan.